181 related articles for article (PubMed ID: 35891147)
1. Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated
Bagwe P; Bajaj L; Gala RP; D'Souza MJ; Zughaier SM
Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891147
[TBL] [Abstract][Full Text] [Related]
2. Gonococcal microparticle vaccine in dissolving microneedles induced immunity and enhanced bacterial clearance in infected mice.
Bagwe P; Bajaj L; Menon I; Braz Gomes K; Kale A; Patil S; Vijayanand S; Gala R; D'Souza MJ; Zughaier SM
Int J Pharm; 2023 Jul; 642():123182. PubMed ID: 37369287
[TBL] [Abstract][Full Text] [Related]
3. Novel Whole-Cell Inactivated
Gala RP; Zaman RU; D'Souza MJ; Zughaier SM
Vaccines (Basel); 2018 Sep; 6(3):. PubMed ID: 30181504
[No Abstract] [Full Text] [Related]
4. An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice.
Vijayanand S; Patil S; Menon I; Braz Gomes K; Kale A; Bagwe P; Uddin MN; Zughaier SM; D'Souza MJ
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986756
[TBL] [Abstract][Full Text] [Related]
5. Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus.
Vijayanand S; Patil S; Joshi D; Menon I; Braz Gomes K; Kale A; Bagwe P; Yacoub S; Uddin MN; D'Souza MJ
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146568
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Microparticulate (S)-4,5-Dihydroxy-2,3-pentanedione (DPD) as a Potential Vaccine Adjuvant.
Joshi D; Chbib C; Uddin MN; D'Souza MJ
AAPS J; 2021 Jun; 23(4):84. PubMed ID: 34131810
[TBL] [Abstract][Full Text] [Related]
7. Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response.
Menon I; Kang SM; Braz Gomes K; Uddin MN; D'Souza M
Vaccine; 2023 Feb; 41(6):1209-1222. PubMed ID: 36631361
[TBL] [Abstract][Full Text] [Related]
8. Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticles.
Ubale RV; Gala RP; Zughaier SM; D'Souza MJ
AAPS J; 2014 Sep; 16(5):986-93. PubMed ID: 24981893
[TBL] [Abstract][Full Text] [Related]
9. A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine.
Tzeng TT; Chai KM; Chen IH; Chang RY; Chiang JR; Liu SJ
Emerg Microbes Infect; 2023 Dec; 12(2):2249130. PubMed ID: 37585273
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
11. Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration.
Kale A; Joshi D; Menon I; Bagwe P; Patil S; Vijayanand S; Braz Gomes K; D'Souza M
Int J Pharm; 2022 Aug; 624():121975. PubMed ID: 35787459
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular polysaccharide-based vaccine.
Gala RP; D'Souza M; Zughaier SM
Vaccine; 2016 Jun; 34(28):3260-7. PubMed ID: 27177946
[TBL] [Abstract][Full Text] [Related]
13. Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice.
Huang MH; Lin SC; Hsiao CH; Chao HJ; Yang HR; Liao CC; Chuang PW; Wu HP; Huang CY; Leng CH; Liu SJ; Chen HW; Chou AH; Hu AY; Chong P
PLoS One; 2010 Aug; 5(8):e12279. PubMed ID: 20808862
[TBL] [Abstract][Full Text] [Related]
14. Subunit microparticulate vaccine delivery using microneedles trigger significant SARS-spike-specific humoral and cellular responses in a preclinical murine model.
Patil S; Vijayanand S; Joshi D; Menon I; Braz Gomes K; Kale A; Bagwe P; Yacoub S; Uddin MN; D'Souza MJ
Int J Pharm; 2023 Feb; 632():122583. PubMed ID: 36610521
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.
Baarda BI; Zielke RA; Holm AK; Sikora AE
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536323
[TBL] [Abstract][Full Text] [Related]
16. Association of Neisseria gonorrhoeae Opa(CEA) with dendritic cells suppresses their ability to elicit an HIV-1-specific T cell memory response.
Yu Q; Chow EM; McCaw SE; Hu N; Byrd D; Amet T; Hu S; Ostrowski MA; Gray-Owen SD
PLoS One; 2013; 8(2):e56705. PubMed ID: 23424672
[TBL] [Abstract][Full Text] [Related]
17. Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
Lone NA; Spackman E; Kapczynski D
Vaccine; 2017 Jun; 35(26):3401-3408. PubMed ID: 28511853
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations.
Nicholson KG; Thompson CI; Klap JM; Wood JM; Batham S; Newman RW; Mischler R; Zambon MC; Stephenson I
Vaccine; 2009 Dec; 28(1):171-8. PubMed ID: 19799843
[TBL] [Abstract][Full Text] [Related]
19. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
20. Structure of the Recombinant
Almonacid-Mendoza HL; Humbert MV; Dijokaite A; Cleary DW; Soo Y; Hung MC; Orr CM; Machelett MM; Tews I; Christodoulides M
mSphere; 2018 Oct; 3(5):. PubMed ID: 30305317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
